(Q53914539)

English

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

13

object named as

Eiji Tanaka

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

author name string

Naoyuki Fujimori

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Naoki Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Soichiro Shibata

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Kenji Sano

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Tomoo Yamazaki

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Tomohiro Sekiguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Hiroyuki Kitabatake

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Yuki Ichikawa

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Takefumi Kimura

9

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Michiharu Komatsu

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Takeji Umemura

11

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Akihiro Matsumoto

12

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

publication date

15 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

46

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

1019-1027

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Human fatty liver disease: old questions and new insights

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Non-invasive evaluation of liver fibrosis using transient elastography

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

New criteria for 'obesity disease' in Japan.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Down-regulation of SREBP-1c is associated with the development of burned-out NASH.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12649

21 January 2018

Identifiers

10.1111/HEPR.12649

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/27183219

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53914539&oldid=1779214850"